ПОЛИМОРФИЗМ ГЕНА ЭНДОТЕЛИАЛЬНОЙ СИНТАЗЫ ОКСИДА АЗОТА И САХАРНЫЙ ДИАБЕТ 2 ТИПА (литературный обзор)
https://doi.org/10.20514/2226-6704-2014-0-6-34-37
Abstract
This review is devoted to a problem of interpretations of scientific data in the field of genes polymorphism researches, especially endothelial nitric oxide synthase. It is difficult to evaluate gene associations with variety of clinically significant conditions. To define associations is essential in patients with diabetes mellitus because of its cardiovascular complications. The data about associations gives us abilities to develop new targets and tactics, providing personal approach to a disease management.
About the Authors
Ю. А. Сорокина
ГБОУ ВПО «Нижегородская государственная медицинская академия», кафедра общей и клинической фармакологии, г. Нижний Новгород
Russian Federation
Russian Federation
Л. В. Ловцова
ГБОУ ВПО «Нижегородская государственная медицинская академия», кафедра общей и клинической фармакологии, г. Нижний Новгород
Russian Federation
Russian Federation
References
1. Aminuddin F. Nitric oxide synthase polymorphisms, gene expression and lung function in chronic obstructive pulmonary disease // BMC Pulm Med. 2013. Vol. 13. P. 64.
2. Bazzaz J.T. eNOS gene polymorphism association with retinopathy in type 1 diabetes // Ophthalmic Genet. 2010. Vol. 31, No 3. P. 103–107.
3. Bressler J. Interaction between the NOS3 gene and obesity as a determinant of risk of type 2 diabetes: the Atherosclerosis Risk in Communities study // PLoS One. 2013. Vol. 8, No 11. Р. 3–12.
4. Cilenšek I. The 4a/4a genotype of the VNTR polymorphism for endothelial nitric oxide synthase (eNOS) gene predicts risk for proliferative diabetic retinopathy in Slovenian patients (Caucasians) with type 2 diabetes mellitus // Mol. Biol. Rep. 2012. Vol. 39, No 6. P. 7061–7067.
5. Grøntved A. et al. NOS3 variants, physical activity, and blood pressure in the European Youth Heart Study // Am. J. Hypertens. 2011. Vol. 24, No 4. P. 444–450.
6. Jia Z. et al. Association of endothelial nitric oxide synthase gene polymorphisms with type 2 diabetes mellitus: a meta-analysis // Endocr. J. 2013. Vol. 60, No 7. Р. 893–901.
7. Joshi M.S. Effects of human endothelial gene polymorphisms on cellular responses to hyperglycaemia: role of NOS3 (Glu298Asp) and ACE (I/D) polymorphisms // Diab. Vasc. Res. 2011. Vol. 8, No 4. P.276–283.
8. Katakami N. et al. Accumulation of oxidative stress-related gene polymorphisms and the risk of coronary heart disease events in patients with type 2 diabetes An 8-year prospective study // Atherosclerosis. 2014. Vol. 235, No 2. P. 408–414.
9. Kuricova K. et al. NOS3 894 G> T polymorphism is associated with progression of kidney disease and cardiovascular morbility in type 2 diabetic patients:NOS3 as modifier gene for diabetic nephropathy? // Kidney Blood Press Res. 2013. Vol. 38, No 1. P. 92–98.
10. Liu C.S. et al. Association between endothelial nitric oxide synthase polymorphisms and risk of metabolic syndrome // Dis. Markers. 2013. Vol. 34, No 3. P. 187–197.
11. Luk A.O. et al. Predictive role of polymorphisms in interleukin-5 receptor alpha-subunit, lipoprotein lipase, integrin A2 and nitric oxide synthase genes on ischemic stroke in type 2 diabetes, an 8-year prospective cohort analysis of 1327 Chinese patients // Atherosclerosis. 2011. Vol. 215, No 1. P. 130–135.
12. Lunder M. et al. Treatment with low-dose atorvastatin, losartan, and their combination increases expression of vasoactive-related genes in rat aortas // Cardiovasc. Pharmacol. Ther. 2013. Vol. 18, No 2. P. 177–183.
13. Makuc J., Petrovic D. No association between NOS2 and NOS3 polymorphisms and diabetic nephropathy in type 2 diabetics // Cent. Eur. J. Biol. 2012. Vol. 7. P. 404–410.
14. Marsden P.A. et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene // J. Biol. Chem. 1993. Vol. 268. P. 17478–17488.
15. McKnight A.J. et al. Genetic polymorphisms in nitric oxide synthase 3 gene and implications for kidney disease: a meta-analysis // Am. J. Nephrol. 2010. Vol. 32, No 5. P. 476–481.
16. Mehrab-Mohseni M. et al. Endothelial nitric oxide synthase VNTR (intron 4 a/b) polymorphism association with type 2 diabetes and its chronic complications // Diabetes Res. Clin. Pract. 2011. Vol. 91, No 3. P. 348–352.
17. Monisha B., Vats P. Reactive metabolites and antioxidant gene polymorphisms in type 2 diabetes mellitus // Indian Journal of Human Genetics. 2014. Vol. 20, No 1. P. 10–19.
18. Patel H. et al. Hyperglycemia induces differential change in oxidative stress at gene expression and functional levels in HUVEC and HMVEC // Cardiovasc. Diabetolog. 2013. Vol. 12. P. 14.
19. Piatti P.M. et al..Effect of normalization of fasting glucose by intensified insulin therapy and influence of eNOS polymorphisms on the incidence of restenosis after peripheral angioplasty in patients with type 2 diabetes: a randomized, open-label clinical trial // Acta. Diabetol. 2013. Vol. 50, No 3. P. 373–382.
20. Ryk C. et al. Polymorphisms in nitric-oxide synthase 3 may influence the risk of urinary-bladder cancer // Nitric Oxide. 2011. Vol. 25, No 3. P. 338–343.
21. Saini V., Bhatnagar M.K. Endothelial nitric oxide synthase Glu298Asp (G894T) gene polymorphism in coronary artery disease patients with type 2 diabetes mellitus //Diab. Metab. Syndr. 2012. Vol. 6, No 2. P.106–109.
22. Santos K.G. et al. Association of eNOS gene polymorphisms with renal disease in Caucasians with type 2 diabetes // Diab. Res. Clin. Pract. 2011. Vol. 91, No 3. P. 353–362.
23. Shoukry A. et al. Endothelial nitric oxide synthase gene polymorphisms and the risk of diabetic nephropathy in type 2 diabetes mellitus // Genet. Test Mol. Biomarkers. 2012. Vol. 16, No 6. P. 574–579.
24. Vasku A. et al. Association of the eNOS 4a/b and -786T/C polymormphisms with coronary artery disease, obesity and diabetes mellitus // Folia Biol. (Praha). 2009. Vol. 55, No 5. P. 187–191.
25. Wu J.H. et al. Association of endothelia nitric oxide synthase gene rs 1799983 polymorphism with susceptibility to prostate cancer: a meta-analysis // Tumour Biol. 2014. Vol. 35, No 7. P. 7057–7062.
26. Zeng Z. et al. A meta-analysis of three polymorphisms in the endothelial nitric oxide synthase gene (NOS3) and their effect on the risk of diabetic nephropathy // Hum. Genet. 2010. Vol. 127, No 4. P. 373–781.
27. Zhang Y. et al. The -786T > C polymorphism in the NOS3 gene is associated with increased cancer risk // Tumour Biol. 2014. Vol. 35, No 4. P. 3535–3540.
28. Zhao S. et al. Nitric oxide synthase 3 (NOS3) 4b/a, T-786C and G894T polymorphisms in association with diabetic retinopathy susceptibility: a meta-analysis // Ophthalmic Genet. 2012. Vol. 33, No 4. P. 200–207.
29. Zintzaras E., Papathanasiou A.A., Stefanidis I. Endothelial nitric oxide synthase gene polymorphisms and diabetic nephropathy: a HuGE review and meta-analysis // Genet. Med. 2009. Vol. 11, No 10. Р.695–706.
Review
For citations:
Сорокина Ю.А., Ловцова Л.В. ПОЛИМОРФИЗМ ГЕНА ЭНДОТЕЛИАЛЬНОЙ СИНТАЗЫ ОКСИДА АЗОТА И САХАРНЫЙ ДИАБЕТ 2 ТИПА (литературный обзор). The Russian Archives of Internal Medicine. 2014;(6):34-37. (In Russ.) https://doi.org/10.20514/2226-6704-2014-0-6-34-37
Views:
846
Email this article 